In addition, pioglitazone treatment modestly ameliorates rheumatoid arthritis (RA) activity by preventing bone loss [37] and suppresses plasma levels of cytokines, including TNF-α, IL-1β, and IL-6 [38]. The gene discussed is TNF; the disease is rheumatoid arthritis.